alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### D ISTRICT 

### C OURT 

### O F 

### A PPEAL 

### O F 

### T HE 

### S TATE 

### O F 

### F LORIDA

F OURTH D ISTRICT

NICOLAS DOMINIQUE

, Appellant,

v.

STATE OF FLORIDA

, Appellee

.

No. 4D 2 02 4

- 0312

[ June 6, 2024 ]

Appeal of order denying rule 3.8 00 motion from the Circuit Court for

the Seven t eenth J udicial Circuit, Broward County ; Michael Rothschild

, J udge; L.T. Case No. 05

- 17224 CF 10A

.

Nicolas Dominique

, Live Oak

, pro se

.

No appearance required for appellee.

P ER C URIAM

.

Affirmed.

M AY

, K UNTZ and A RTAU

, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
STATE v. BELL

No. COA05-268

North Carolina Court of Appeals

Filed February 7, 2006

Certification Date February 27, 2006

Appeal from Gaston (02CRS13488, 02CRS13493, 02CRS13494, 02CRS13495, 02CRS13496).

Case reported without published opinion. No prejudicial error.
10-Q Exhibit 32.2: Certifications Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of iShares COMEX Gold Trust (the Trust) on Form 10-Q for the
quarter ended September 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Michael A. Latham, Chief Financial Officer of Barclays Global Investors International, Inc., the Sponsor of
the Trust, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully
complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the
Report fairly presents, in all material respects, the financial condition and results of operations of the Trust at the dates and for the periods indicated.



|                              |  |                 
|----------------------------- |  | ----------------
|Date:                         |  | November 7, 2008
|                             
|/s/ Michael A. Latham        
|Michael A. Latham *          
|Chief Financial Officer      
|(Principal financial officer)



|* | The Registrant is a trust and Mr. Latham is signing in his capacity as an officer of Barclays Global Investors International, Inc., the Sponsor of the Registrant.
|- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------
Puradyn Filter Technologies, Incorporated
3020 High Ridge Road, Suite 100
Boynton Beach, FL 33426

                          INDEPENDENT AUDITOR'S CONSENT

Ladies and Gentlemen:


We hereby consent to the incorporation by reference in the Registration
Statement of Puradyn Filter Technologies Incorporated on Form S-8 of our report
dated March 5, 1999 on the financial statements of the company, as of December
31, 1998 and for the year ended, included in the Company's 1998 Annual Report on
Form 10-KSB.









                                                /s/Durland & Company, CPAs, P.A.
                                                   Durland & Company, CPAs, P.A.

Palm Beach, Florida
June 11, 1999
STATE v. MAXWELL.

No. COA05-1220.

North Carolina Court of Appeals.

Filed June 6, 2006

Certification Date June 26, 2006

Appeal from Craven (04CRS55726)

Case without published opinion. No error.
xml version="1.0" encoding="UTF-8"?


L\_2023017DE.01010001.xml


| | | | |
| --- | --- | --- | --- |
| 19.1.2023 | DE | Amtsblatt der Europäischen Union | L 17/100 |

---

Berichtigung der Durchführungsverordnung (EU) Nr. 923/2012 der Kommission vom 26. September 2012 zur Festlegung gemeinsamer Luftverkehrsregeln und Betriebsvorschriften für Dienste und Verfahren der Flugsicherung und zur Änderung der Durchführungsverordnung (EG) Nr. 1035/2011 sowie der Verordnungen (EG) Nr. 1265/2007, (EG) Nr. 1794/2006, (EG) Nr. 730/2006, (EG) Nr. 1033/2006 und (EU) Nr. 255/2010

(
[Amtsblatt der Europäischen Union L 281 vom 13. Oktober 2012](http://publications.europa.eu/resource/oj/JOL_2012_281_R_TOC)
)

Seite 32, Anhang Abschnitt 9 Punkt SERA.9010 Buchstabe b Nummer 9:

Anstatt:

| | |
| --- | --- |
| „9. | Abflugverspätung, falls zutreffend;“ |

muss es heißen:

| | |
| --- | --- |
| „9. | An- und Abflugverspätung, falls zutreffend;“. |

Seite 33, Anhang Abschnitt 9 Punkt SERA.9010 Buchstabe c Nummer 9:

Anstatt:

| | |
| --- | --- |
| „9. | Abflugverspätung, falls zutreffend;“ |

muss es heißen:

| | |
| --- | --- |
| „9. | Anflugverspätung, falls zutreffend;“. |

---
**Exhibit      32.2**

**CERTIFICATION      PURSUANT TO 18 U.S.C. SECTION 1350**

**AS      ADOPTED PURSUANT TO**

**SECTION      906 OF THE SARBANES-OXLEY ACT OF 2002**

|  | (1) | The                Report fully complies with the requirements of Section 13(a) or 15(d)                of                the Securities Exchange Act of 1934, as amended, and |
|--|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | The                information contained in the Report fairly presents in all material                respects the financial condition and results of operations of the                Company. |
|--|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|    |                                                                                                 |  /s/                Winston Yen |
|--------------|-----------------------------------------------------------------------------------------------------------|--------------------------------------|
|         | Winston                YenChief                Financial OfficerDate: August                14, 2007 |

----
# L_2012307EN.01000501.xml

| 7.11.2012 | EN | Official Journal of the European Union | L 307/5 |
| --- | --- | --- | --- |

7.11.2012

EN

Official Journal of the European Union

L 307/5

---

COUNCIL IMPLEMENTING REGULATION (EU) No 1016/2012

of 6 November 2012

implementing Regulation (EU) No 267/2012 concerning restrictive measures against Iran

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Council Regulation (EU) No 267/2012 of 23 March 2012 concerning restrictive measures against Iran (1), and in particular Article 46(2) thereof,

Whereas:

| (1) | On 23 March 2012, the Council adopted Regulation (EU) No 267/2012. |
| --- | --- |

(1)

On 23 March 2012, the Council adopted Regulation (EU) No 267/2012.

| (2) | In accordance with Council Decision 2012/687/CFSP of 6 November 2012 amending Decision 2010/413/CFSP concerning restrictive measures against Iran (2), an additional entity should be included in the list of natural and legal persons, entities and bodies subject to restrictive measures set out in Annex IX to Regulation (EU) No 267/2012, |
| --- | --- |

(2)

In accordance with Council Decision 2012/687/CFSP of 6 November 2012 amending Decision 2010/413/CFSP concerning restrictive measures against Iran (2), an additional entity should be included in the list of natural and legal persons, entities and bodies subject to restrictive measures set out in Annex IX to Regulation (EU) No 267/2012,

HAS ADOPTED THIS REGULATION:

Article 1

The entity listed in the Annex to this Regulation shall be added to Section B of Part I of the list set out in Annex IX to Regulation (EU) No 267/2012.

Article 2

This Regulation shall enter into force on the date of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 6 November 2012.

For the Council

The President

A. D. MAVROYIANNIS

---

(1)  
  OJ L 88, 24.3.2012, p. 1.

1

(2)  See page 82 of this Official Journal.

2

---

ANNEX

ENTITY REFERRED TO IN ARTICLE 1

B.   Entities

| | Name | Identifying information | Reasons | Date of listing |
| --- | --- | --- | --- | --- |
| 1. | National Iranian Oil Company Nederland (a.k.a.: NIOC Netherlands Representation Office) | Blaak 512, 3011 TA and Weena 333, 3013 AL Rotterdam, Netherlands.
  Tel +31 (10) 225 0177, +31 (10) 225 0308.
  http://www.nioc-intl.com/Offices_Rotterdam.htm. | Subsidiary of the National Iranian Oil Company (NIOC). | 7.11.2012 |

Name

Identifying information

Reasons

Date of listing

1.

National Iranian Oil Company Nederland (a.k.a.: NIOC Netherlands Representation Office)

Blaak 512, 3011 TA and Weena 333, 3013 AL Rotterdam, Netherlands.

Tel +31 (10) 225 0177, +31 (10) 225 0308.

http://www.nioc-intl.com/Offices_Rotterdam.htm.

Subsidiary of the National Iranian Oil Company (NIOC).

7.11.2012

---
## I N T H E C O U R T O F C R I M I N A L A P P E A L S O F T E X A S NO. WR-87,017-01

EX P ARTE DAMM OND DEF F ERAL JOHNSO N, Applicant

ON AP P LICATION FOR A WRIT OF HABEAS CORP US CAUSE NO. CR13-441A IN THE 235T H DISTRICT COURT

F ROM COOK

E COUNTY

Per curiam . O R D E R Pursuant to the provisions of Article 11.07 of the T ex as C o d e of Criminal Procedur e, the cler k of the trial court transmitted to this Court this application for a writ of habea s corpus. Ex parte Y oung , 418 S.W .2d 824, 826 (Tex. Crim. App. 1967). Applican t wa s co n victed of ag g ravated robber y and sentenc ed to thirty -eig ht y ear s’ imprisonment. The Second Court of Appea ls aff irmed his conviction. Johnson v. State , No. 02-15-00101- CR (Te x . App. — For t Worth, Aug . 25, 2016) (not desig nated f

or publication). A p p li c a n t c o n te n d s th a

t h is a p p e ll a te c ounsel rende red ineffe ctive assistance beca use co u n s e l failed to timely notify Applicant that his conviction had been aff irmed and failed to advise him of his right to petition pro se for discr etionary revie w.2

Applicant has alleg ed fac ts that, if true, might entitle him to relief

. Strickland v. W

ashington , 466 U.S. 668 (1984); Ex parte W ilson , 956 S.W .2d 25 (Tex. Crim. App. 1997). I n these circ umstances, additional fac ts a re neede d. Pursuant to Ex parte Rodriguez , 334 S.W .2d 294, 294 (Tex. Crim. App. 1960), the trial court is the appropr iate forum for finding s of fac t. The trial court shall order appellate counsel to respond to Applicant’s claim of ineffe ctive assistance of counsel on appea l. The trial cour

t may use any means set out in T E X . C O D E C R I M . P R O C . art. 11.07, § 3(d)

. I f the trial c ourt elec ts to hold a hearing , it shall determine whe ther Applicant is indig ent. I f Applicant is indige nt and wishes to be repr esente d by counsel, t h e t ri al court shall appoint an attorney to repre sent Applicant a t the hear ing. T E X . C O D E C R I M . P R O C . art. 26.04. The trial court shall make finding s of fac t and conclusions of law as to whether Applicant’s appellate counsel timely informed Applica nt that his conviction had been aff irmed and that he has

a rig ht to file a pro se petition for discretionar y revie w. The trial co u rt s h all also make any other finding s of fa ct and c onclusions of law that it dee ms releva nt and appr opriate to the dispositi on of Applicant’s c laim for habe as cor pus relief

. This application will be held in abey ance until the trial court has resolved the fac t issues. The i s s u es s h al l be resolved within 90 day s of this order

. A supplemental transcr ipt containing all aff idavits and int err og atories or the t ransc ription of t he court repor ter’s notes from any hear ing or deposition, along with the trial court’ s supplemental finding s of fa ct and c onclusions of law, shall be forwar ded to this Court wit hin 120 day s of the date of this order. A ny extensions of ti me must be re quested by

the trial cour

t and shall be obtaine d from this Court.

Filed: Jul y

26, 2017 Do not publish
CONVERGENCE COMMUNICATIONS, INC.

SCHEDULE II:  VALUATION AND QUALIFYING ACCOUNTS

<TABLE>
<CAPTION>
                                                                Additions
                                                        -------------------------
                                        Balance-at-      Charged-       Charged-      Deductions    Balance-at-
                                     Beginning-of-Year   to-Cash-      to-Other-                        End-of-
                                                           and-         Accounts                           Year
                                                         Expenses
       Description
<S>                                     <C>           <C>             <C>            <C>           <C>
Year-ended-December-31,-1999:

Deducted-from-assets-accounts
Accounts-Receivable:

   Allowance                            $   328,283   $   363,005                    $   324,840    $   366,448
Inventory:
   Reserve                                  259,579                                                     259,579
Deferred-tax-assets:
   Valuation-allowance                    5,452,292                    4,644,076                     10,096,368

Year-ended-December-31,-1998:

Deducted-from-assets-accounts
Accounts-receivable:
   Allowance                           -----------        328,283                                       328,283
Inventory:
   Reserve                             -----------        259,579                                       259,579
Deferred-tax-assets:
   Valuation-allowance                    1,550,426                    3,901,866                      5,452,292

Year-ended-December-31,-1997:

Deducted-from-assets-accounts
Accounts-receivable:
   Allowance                            -----------
Inventory:
   Reserve                              -----------
Deferred-tax-assets:
   Valuation-allowance                      398,610                    1,151,816                      1,550,426

</TABLE>
Exhibit 6.1  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the annual report on Form 40-F of Virginia Mines Inc. for the year ended February 28, 2011, as filed with the Securities and Exchange Commission, I hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:  1. The annual report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and  2. The information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of the issuer.   Date:  May19, 2011   /s/ André Gaumond André Gaumond President and Chief Executive Officer     A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Issuer and will be retained by the Issuer and furnished to the Securities and Exchange Commission or its staff upon request.
**EXHIBIT
32.1**





**CERTIFICATION
PURSUANT TO**


**18
U.S.C. SECTION 1350,**


**AS
ADOPTED PURSUANT TO**


**SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002**








In
connection with the Quarterly Report of Atlas America, Inc. (the "Company") on
Form 10-Q for the quarterly period ended March 31, 2005 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Edward
E. Cohen, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:





(1)
    The
      Report fully complies with the requirements of section 13(a) or 15(d) of
      the Securities Exchange Act of 1934, and





(2)
    The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.




/s/*Edward
      E. Cohen*Edward
      E. CohenChairman
      of the Board and Chief Executive OfficerMay
      12,
      2005
I 

110TH CONGRESS 

1ST SESSION H. R. 56 

To extend the supplemental security income benefits program to Guam and 

the United States Virgin Islands. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 4, 2007 

Mrs. CHRISTENSEN introduced the following bill; which was referred to the 

Committee on Ways and Means 

A BILL 

To extend the supplemental security income benefits program 

to Guam and the United States Virgin Islands. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. EXTENSION OF THE SUPPLEMENTAL SECURITY 

4 INCOME BENEFITS PROGRAM TO GUAM AND 

5 THE UNITED STATES VIRGIN ISLANDS. 

6 (a) IN GENERAL.—Section 1101(a)(1) of the Social 

7 Security Act (42 U.S.C. 1301(a)(1)) is amended by strik8 ing ‘‘, the Virgin Islands, and Guam’’ each place such 

9 term appears. 

10 (b) CONFORMING AMENDMENTS.— 


rwilkins on PROD1PC63 with BILLS
2 

•HR 56 IH

1 (1) Section 303(b) of the Social Security 

2 Amendments of 1972 (86 Stat. 1484) is amended by 

3 striking ‘‘, Guam, and the Virgin Islands’’. 

4 (2) Sections 3(a)(2), 1003(a)(2), 1403(a)(2), 

5 and 1603(a)(2) of such Act (42 U.S.C. 303(a)(2), 

6 1203(a)(2), 1353(a)(2), and 1383 note) are each 

7 amended by striking ‘‘, the Virgin Islands, and 

8 Guam’’. 

9 (3) Section 1614(e) of such Act (42 U.S.C. 

10 1382c(e)) is amended by striking ‘‘and the District 

11 of Columbia’’ and inserting ‘‘, the District of Colum12 bia, the Virgin Islands, and Guam’’. 

13 (c) EFFECTIVE DATE.—The amendments made by 

14 this section shall take effect on the 1st day of the 3rd 

15 calendar month that begins after the date of the enact16 ment of this Act. 

Æ 


rwilkins on PROD1PC63 with BILLS
Exhibit
        32.1
 **CERTIFICATION
        PURSUANT TO**
 **18
        U.S.C. SECTION 1350,**
 **AS
        ADOPTED PURSUANT TO**
 **SECTION
        906 OF THE SARBANES-OXLEY ACT OF 2002**
 
 In
        connection with the Annual Report on Form 10-KSB of International Food Products
        Group, Inc. (the “ ***Company*** ”),
        for
        the year ended June 30, 2005, as filed with the Securities and Exchange
        Commission on the date hereof (the “ ***Report*** ”),
        I,
        Richard Damion, Chief Executive Officer of the Company, pursuant to 18 U.S.C.
§
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
        do
        hereby certify, to my knowledge that:
 
 (1)  The
        Report fully complies with the requirements of Section 13(a) or 15(d) of
        the
        Securities Exchange Act of 1934 15 U.S.C. 78m (a) or 780(d)); and
 
 (2)  The
        information contained in the Report fairly presents, in all material respects,
        the financial condition and results of operations of the Company.
 
 
 /s/
        Richard Damion
 __________________________________________
 Richard
        Damion
 Chief
        Executive Officer
 
 Dated:  January
        17, 2006
 
 
 A
        signed
        original of this written statement required by Section 906 has been provided
        to
        International Food Products Group, Inc. and will be retained by International
        Food Products Group, Inc. and furnished to the Securities and Exchange
        Commission or its staff upon request.
<TABLE> <S> <C>

<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                             DEC-31-1998
<PERIOD-END>                                  DEC-31-1998
<CASH>                                        0
<SECURITIES>                                  0
<RECEIVABLES>                                 65,623
<ALLOWANCES>                                  (35,000)
<INVENTORY>                                   342,439
<CURRENT-ASSETS>                              373,269
<PP&E>                                        601,993
<DEPRECIATION>                                (312,676)
<TOTAL-ASSETS>                                678,956
<CURRENT-LIABILITIES>                         1,431,890
<BONDS>                                       0
<PREFERRED-MANDATORY>                         0
<PREFERRED>                                   0
<COMMON>                                      5,223
<OTHER-SE>                                    (3,592,404)
<TOTAL-LIABILITY-AND-EQUITY>                  678,956
<SALES>                                       708,028
<TOTAL-REVENUES>                              708,028
<CGS>                                         579,508
<TOTAL-COSTS>                                 1,842,091
<OTHER-EXPENSES>                              0
<LOSS-PROVISION>                              0
<INTEREST-EXPENSE>                            347,518
<INCOME-PRETAX>                               (2,061,089)
<INCOME-TAX>                                  0
<INCOME-CONTINUING>                           (2,061,089)
<DISCONTINUED>                                0
<EXTRAORDINARY>                               0
<CHANGES>                                     0
<NET-INCOME>                                  (2,061,089)
<EPS-BASIC>                                 (.40)
<EPS-DILUTED>                                 (.40)


</TABLE>
STATE v. BYRD.

No. COA05-397.

North Carolina Court of Appeals.

Filed June 6, 2006

Certification Date June 26, 2006

Appeal from Craven (02CRS55245, 02CRS55246, 03CRS5447)

Case without published opinion. No error.
```

[Federal Register Volume 87, Number 134 (Thursday, July 14, 2022)]
[Notices]
[Page 42198]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-15069]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Research Education Program, 
Advancing the Careers of a Diverse Research Workforce (R25 Clinical 
trial Not Allowed).
    Date: August 9, 2022.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G31B, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: James T. Snyder, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G31B, 
Rockville, MD 20852, (240) 669-5060, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: July 8, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-15069 Filed 7-13-22; 8:45 am]
BILLING CODE 4140-01-P
```